- Home
- KLXE vs SNTI Comparison
KLXE vs SNTI Comparison
Compare KLXE & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLXE
- SNTI
- Stock Information
- Founded
- KLXE 2018
- SNTI 2016
- Country
- KLXE United States
- SNTI United States
- Employees
- KLXE N/A
- SNTI N/A
- Industry
- KLXE Oilfield Services/Equipment
- SNTI Biotechnology: Pharmaceutical Preparations
- Sector
- KLXE Energy
- SNTI Health Care
- Exchange
- KLXE Nasdaq
- SNTI Nasdaq
- Market Cap
- KLXE 35.8M
- SNTI 39.6M
- IPO Year
- KLXE N/A
- SNTI N/A
- Fundamental
- Price
- KLXE $2.00
- SNTI $1.78
- Analyst Decision
- KLXE
- SNTI Strong Buy
- Analyst Count
- KLXE 0
- SNTI 2
- Target Price
- KLXE N/A
- SNTI $8.50
- AVG Volume (30 Days)
- KLXE 99.4K
- SNTI 139.1K
- Earning Date
- KLXE 10-30-2025
- SNTI 11-13-2025
- Dividend Yield
- KLXE N/A
- SNTI N/A
- EPS Growth
- KLXE N/A
- SNTI N/A
- EPS
- KLXE N/A
- SNTI N/A
- Revenue
- KLXE $667,400,000.00
- SNTI N/A
- Revenue This Year
- KLXE N/A
- SNTI N/A
- Revenue Next Year
- KLXE $1.93
- SNTI $150.00
- P/E Ratio
- KLXE N/A
- SNTI N/A
- Revenue Growth
- KLXE N/A
- SNTI N/A
- 52 Week Low
- KLXE $1.46
- SNTI $1.26
- 52 Week High
- KLXE $7.40
- SNTI $16.94
- Technical
- Relative Strength Index (RSI)
- KLXE 57.07
- SNTI 73.44
- Support Level
- KLXE $1.92
- SNTI $1.36
- Resistance Level
- KLXE $2.04
- SNTI $1.75
- Average True Range (ATR)
- KLXE 0.10
- SNTI 0.08
- MACD
- KLXE 0.01
- SNTI 0.05
- Stochastic Oscillator
- KLXE 60.39
- SNTI 95.45
About KLXE KLX Energy Services Holdings Inc.
KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.